New Study Offers Additional Evidence for the VASCADE MVP® XL System's Effectiveness in Electrophysiology Procedures with Large Bore Sheaths
Go back to New Study Offers Additional Evidence for the VASCADE MVP® XL System's Effectiveness in Electrophysiology Procedures with Large Bore Sheaths| HAEMONETICS CORPORATION (NYSE: HAE) | Delayed: 102.92 +0.07 (0.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $102.85 | 52 Week High | $39.41 | |||
| Open | $101.59 | 52 Week Low | $25.98 | |||
| Day High | $103.57 | P/E | 144.96 | |||
| Day Low | $101.51 | EPS | $0.71 | |||
| Volume | 425,088 | |||||
